Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Assets Average (2021 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Assets Average for 3 consecutive years, with $280.7 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Assets Average rose 66.36% year-over-year to $280.7 million, compared with a TTM value of $280.7 million through Sep 2023, up 66.36%, and an annual FY2022 reading of $227.5 million, up 74.79% over the prior year.
  • Assets Average was $280.7 million for Q3 2023 at Terns Pharmaceuticals, down from $295.5 million in the prior quarter.
  • Across five years, Assets Average topped out at $295.5 million in Q2 2023 and bottomed at $145.8 million in Q1 2021.
  • Average Assets Average over 3 years is $208.1 million, with a median of $183.9 million recorded in 2021.
  • The sharpest move saw Assets Average decreased 22.14% in 2022, then soared 96.0% in 2023.
  • Year by year, Assets Average stood at $174.0 million in 2021, then surged by 37.84% to $239.8 million in 2022, then increased by 17.05% to $280.7 million in 2023.
  • Business Quant data shows Assets Average for TERN at $280.7 million in Q3 2023, $295.5 million in Q2 2023, and $294.2 million in Q1 2023.